ScienceDaily (Dec. 3, 2009) — Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular signaling pathway in these cancer stem cells, they were able to kill many more glioma cells with radiation in a laboratory experiment.

The work builds off earlier research which showed that cancer stem cells resist the effects of radiation much better than other...

admin

Data From Ongoing Phase 2 Trial Consistent with Survival Outcome Reported in Earlier Phase I Trial


October 26, 2009 07:00 AM Eastern Daylight Time

NEW ORLEANS--(BUSINESS WIRE)--Antigenics (NASDAQ: AGEN) today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO...

admin

Environmental Health News


Shim Y, SP Mlynarek and E van Wijngaarden. Parental exposure to pesticides and childhood brain cancer: United States Atlantic Coast Childhood Brain Cancer Study. Environmental Health Perspectives doi:10.1289/ehp.0800209.
Synopsis by Heather Hamlin

Little is known conclusively about what causes brain cancer in children, but research studies are consistently finding links to prebirth pesticide exposure.

A new study finds...

admin